Advertisement

Ads Placeholder
Loading...

Botanix Pharmaceuticals Limited

BXPHF•PNK
Healthcare
Biotechnology
$0.03
$0.00(0.00%)
U.S. Market opens in 3h 35m

Botanix Pharmaceuticals Limited (BXPHF) Stock Overview

Explore Botanix Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap62.6M
P/E Ratio-0.88
EPS (TTM)$-0.03
ROE-1.31%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.05
3 Months$0.00
1 Year Target$0.09

BXPHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Botanix Pharmaceuticals Limited (BXPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 27.20, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.88 and a market capitalization of 62.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-33.49%
3-Month Change
-75.46%
6-Month Change
-74.36%
Year-to-Date (YTD) Change
-64.42%
1-Year Change
-88.72%
3-Year Change
-43.60%
5-Year Change
-64.75%
All-Time (Max) Change
-85.90%

Contact Information

https://www.botanixpharma.com
61 8 6555 2945
D2, 661 Newcastle Street, Leederville, WA, 6007

Company Facts

110 Employees
IPO DateSep 9, 2019
CountryAU
Actively Trading

Frequently Asked Questions